Holly Wobma
Holly completed an MD-PhD at Columbia University in New York during which she conducted graduate training in the lab of Gordana Vunjak-Novakovic and helped co-found a cell therapy company called Immplacate. She will soon be starting (June 2019) as a pediatric resident at the Boston Combined Residency Program and is interested in developing and translating cell and gene therapies for pediatric disease.
Posts by: Holly
iPS cell technology – kickstarting our ability to control cell identity
When you hear the word “stem cell,” I imagine this conjures up the image of cells that are special. Unlike most cells, stem cells can differentiate into other cell types. They hold the promise of curing many diseases, and thus they are continually the source of hype in mainstream and social media. Yet the above […]
A gold medal for tissue engineering? Engineered brain organoids lend insight to Zika virus pathology
The summer 2016 Olympics are rapidly approaching and I’ve already been blown away by preview clips of some of the competing athletes performing amazing (and kind of dangerous!) looking stunts. Clouding this year’s games, however, has been the Zika virus outbreak, for which Brazil is at the epicentre. While Zika virus has been seen in […]
Immunotoxins: a surprisingly less toxic approach to stem cell transplants
It is often the case that to produce something ‘shiny,’ new and better, we must first get rid of the old. This is true even in the case of stem cell therapies. Hematopoietic stem cell (HSC) transplants have been around since the mid-twentieth century and are used to treat a broad range of diseases such […]
Comments